Cargando…

Pretreatment Carcinoembryonic Antigen Level Serves as a Potential Biomarker to Guide Adjuvant Radiotherapy in pT4N+ Colon Cancer Patients

The survival benefit of adjuvant radiotherapy in T4 colon cancer (CC) remains controversial, with conflicting results reported in the literature. This study aimed to explore the relationship between pretreatment carcinoembryonic antigen (CEA) level and overall survival (OS) of pT4N+ CC patients trea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Luo, Dakui, Zhang, Ruoxin, Yang, Yufei, Li, Qingguo, Li, Xinxiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9950319/ https://www.ncbi.nlm.nih.gov/pubmed/36844877 http://dx.doi.org/10.1155/2023/4815996

Ejemplares similares

Evaluating the Guiding Role of Elevated Pretreatment Serum Carcinoembryonic Antigen Levels for Adjuvant Chemotherapy in Stage IIA Colon Cancer: A Large Population-Based and Propensity Score-Matched Study
por: Liu, Qi, et al.
Publicado: (2019)

Combination of carcinoembryonic antigen with the American Joint Committee on Cancer TNM staging system in rectal cancer: a real-world and large population-based study
por: Liu, Qi, et al.
Publicado: (2018)

Can Elevated Pretreatment Serum Carcinoembryonic Antigen Levels Serve as a Potential Biomarker Guiding Adjuvant Chemotherapy in Rectal Cancer Patients With ypTis-3N0 After Neoadjuvant Radiotherapy and Surgery?
por: Huang, Chi, et al.
Publicado: (2021)

PROX1 restrains ferroptosis via SCD transcription activation in colorectal cancer: PROX1 inhibits ferroptosis in CRC
por: Zhang, Ruoxin, et al.
Publicado: (2023)

Survival benefit of adjuvant chemotherapy for patients with poorly differentiated stage IIA colon cancer
por: Liu, Qi, et al.
Publicado: (2019)

Associations of P Score With Real-World Survival Improvement Offered by Adjuvant Chemotherapy in Stage II Colon Cancer: A Large Population-Based Longitudinal Cohort Study
por: Liu, Qi, et al.
Publicado: (2021)

Incidence, predictors and prognostic implications of positive circumferential resection margin in colon cancer: A retrospective study in a Chinese high-volume cancer center
por: Luo, Dakui, et al.
Publicado: (2022)

Evaluating the Effect of Lymph Node Status on Survival in Large Colon Cancer
por: Liu, Qi, et al.
Publicado: (2018)

Real-World Implications of Nonbiological Factors with Staging, Prognosis and Clinical Management in Colon Cancer
por: Liu, Qi, et al.
Publicado: (2018)

Effect of interval between neoadjuvant chemoradiotherapy and surgery on oncological outcomes in poor responders with locally advanced rectal cancer: a retrospective cohort study
por: Luo, Dakui, et al.
Publicado: (2023)

P–TNM staging system for colon cancer: combination of P-stage and AJCC TNM staging system for improving prognostic prediction and clinical management
por: Liu, Qi, et al.
Publicado: (2018)

circCAPRIN1 interacts with STAT2 to promote tumor progression and lipid synthesis via upregulating ACC1 expression in colorectal cancer
por: Yang, Yufei, et al.
Publicado: (2022)

A Novel Seventeen-Gene Metabolic Signature for Predicting Prognosis in Colon Cancer
por: Luo, Dakui, et al.
Publicado: (2020)

Is adjuvant radiotherapy warranted in resected pT1-2 node-positive rectal cancer?
por: Peng, Junjie, et al.
Publicado: (2013)

The Correlation Between Survival Benefit of Preoperative Radiotherapy and Pretreatment Carcinoembryonic Antigen Level in Locally Advanced Rectal Cancer
por: Wang, Lei, et al.
Publicado: (2021)

Palliative beam radiotherapy offered real-world survival benefit to metastatic rectal cancer: A large US population-based and propensity score-matched study
por: Liu, Qi, et al.
Publicado: (2019)

Several Carcinoembryonic Antigens (CD66) Serve as Receptors for Gonococcal Opacity Proteins
por: Chen, Tie, et al.
Publicado: (1997)

Evaluation of Traditional Prognostic Factors for Stage I-III Colorectal Cancer Patients Who Survived for Over Five Years After Surgery
por: Luo, Dakui, et al.
Publicado: (2021)

Clinicopathological Features of Stage I–III Colorectal Cancer Recurrence Over 5 Years After Radical Surgery Without Receiving Neoadjuvant Therapy: Evidence From a Large Sample Study
por: Luo, Dakui, et al.
Publicado: (2021)

Survival Benefit of Preoperative Versus Postoperative Radiotherapy in Metastatic Rectal Cancer Treated With Definitive Surgical Resection of Primary Tumor: A Population Based, Propensity Score-Matched Study
por: Luo, Dakui, et al.
Publicado: (2019)

Predictive value of pretreatment lymphocyte count in stage II colorectal cancer and in high-risk patients treated with adjuvant chemotherapy
por: Liang, Lei, et al.
Publicado: (2015)

Localization by immunoperoxidase and estimation by radioimmunoassay of carcinoembryonic antigen in colonic polyps.
por: Sharkey, R. M., et al.
Publicado: (1977)

Clinical Implications of Nonbiological Factors With Colorectal Cancer Patients Younger Than 45 Years
por: Liu, Qi, et al.
Publicado: (2021)

Circumferential resection margin as a prognostic factor after rectal cancer surgery: A large population‐based retrospective study
por: Liu, Qi, et al.
Publicado: (2018)

Circulating basophil count as a prognostic marker of tumor aggressiveness and survival outcomes in colorectal cancer
por: Liu, Qi, et al.
Publicado: (2020)

Adjuvant radiotherapy improves cause specific survival in stage II, not stage III mucinous carcinoma of the rectum
por: Li, Qingguo, et al.
Publicado: (2017)

Carcinoembryonic Antigen and Smoking
por: Clarke, Cyril, et al.
Publicado: (1980)

Carcinoembryonic Antigen and Smoking
por: Clarke, C. A., et al.
Publicado: (1982)

Clinical Management of Low Anterior Resection Syndrome: Review of the Current Diagnosis and Treatment
por: Zhang, Ruijia, et al.
Publicado: (2023)

DIFFERENTIAL EXPRESSION OF CARCINOEMBRYONIC ANTIGEN AND NONSPECIFIC CROSSREACTING ANTIGEN GENES IN HUMAN COLON ADENOCARCINOMAS AND NORMAL COLON MUCOSA
por: Sato, Chieko, et al.
Publicado: (1988)

Carcinoembryonic Antigen in Whole Serum
por: MacSween, J. M., et al.
Publicado: (1972)

Carcinoembryonic antigen (CEA) "fingerprints".
por: Rule, A. H., et al.
Publicado: (1973)

Carcinoembryonic antigen in hepatocellular cancer.
por: Macnab, G. M., et al.
Publicado: (1978)

A Carcinoembryonic Antigen-Secreting Adenocarcinoma Arising in Tailgut Cyst : Clinical Implications of Carcinoembryonic Antigen
por: Cho, Byoung Chul, et al.
Publicado: (2005)

Clinical implication of tissue carcinoembryonic antigen expression in association with serum carcinoembryonic antigen in colorectal cancer
por: Aldilaijan, Abdulmohsin Fawzi, et al.
Publicado: (2023)

ACRNaCT trial protocol: efficacy of adjuvant chemotherapy in patients with clinical T3b/T4, N+ rectal Cancer undergoing Neoadjuvant Chemoradiotherapy: a pathology-oriented, prospective, multicenter, randomized, open-label, parallel group clinical trial
por: Li, Qingguo, et al.
Publicado: (2019)

A Novel Prognostic Model Incorporating Carcinoembryonic Antigen in 3-Week or Longer Postoperative Period for Stage III Colon Cancer: A Multicenter Retrospective Study
por: Fan, Jin, et al.
Publicado: (2020)

High postoperative carcinoembryonic antigen as an indicator of high-risk stage II colon cancer
por: Morimoto, Yoshihiro, et al.
Publicado: (2022)

The correlation between tumor size, lymph node status, distant metastases and mortality in rectal cancer patients without neoadjuvant therapy
por: Luo, Dakui, et al.
Publicado: (2021)

Mapping epitope characteristics on carcinoembryonic antigen.
por: Harwood, P. J., et al.
Publicado: (1986)

Cannot write session to /tmp/vufind_sessions/sess_tqgm4qop31j40lv84ood40hi3h